Skip to main content

Part of the book series: Update in Intensive Care Medicine ((UICMSOFT,volume 34))

  • 369 Accesses

Abstract

Drug-nutrient interactions in the critically ill patient have the potential to lead to decreased drug efficacy and/or increased drug toxicity. With the increased use of specialized nutritional support in patients requiring multiple medications, there is genuine concern about the possibility for pharmacologic-nutritional interactions, and the consequences of therapeutic outcomes [1, 2]. The frequency of drug interactions can be high in the critically ill patient because of the large number of drugs that they receive [3]. According to Sierra, et al. [3] most of these interactions are designated as being of moderate clinical importance with digoxin being the most frequently implicated drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sacks GS, Brown RO (1994) Drug-nutrient interactions in patients receiving nutritional support. Drug Therapy, March, 35–42

    Google Scholar 

  2. Mowatt-Larssen C, Brown R (1994) Drug-nutrient interactions. In: Nutrition in Critical Care, Zaloga GP, ed. Mosby Co., St. Louis, MO, 487–503

    Google Scholar 

  3. Sierra P, Castillo J, Gomez M, Sorribes V, Monterde J, Castano J (1997) Servicio de anestesioilogia, Fundacion Puigvert, Barcelona. Rev Esp Anestesiol Reanim (Spain), Dic., 44 (10), 383–387

    CAS  Google Scholar 

  4. Thomas JA, Tschanz C (1994) Nutrient-drug interactions. In Nutritional Toxicology, Kotsonis FN, Mackey M, Hjelle JJ (eds.), Target Organ Toxicity Series, Raven Press, New York, pp. 139–148

    Google Scholar 

  5. Thomas JA, Burns RA (1998) Important drug-nutrient interactions in the elderly. Drugs and Aging, Sept., 13 (3), 199–209

    Article  CAS  Google Scholar 

  6. Johnson JC (1993) General concepts of geriatric medicine. Clin Podiatr Med Surg, 10 (1) 23–33

    PubMed  Google Scholar 

  7. Landrum-Michalets E (1998) Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy, 18 (1), 84–112

    Google Scholar 

  8. Seshadri V, Meyer-Tettambel OM (1993) Electrolyte and drug management in nutritional support. Crit Care Nurs Clin North Am, March, 5 (1), 31–36

    CAS  Google Scholar 

  9. Varella L, Jones E, Meguid M (1997) Drug-nutrient interactions in enteral feeding: a primary care focus. The Nurse Practitioner, 22 (6):98–104

    Article  PubMed  CAS  Google Scholar 

  10. Parrish CR, MCCray SF, Wolf AM, Wolf AMD (1999) When is nutrition support appropriate? Hospital Medicine, 50–55

    Google Scholar 

  11. Moore FA, Feliciano DV, Andrassy RJ et al. (1992) Early enteral feeding, compared with par-enteral, reduces postoperative septic complications. Ann Surg, 216, 172–178

    Article  PubMed  CAS  Google Scholar 

  12. Windsor ACJ, Kanwar S, Li AG, et al. (1998) Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut, 42, 431–439

    Article  PubMed  CAS  Google Scholar 

  13. Tschanz C, Stargel WW, Thomas JA (1996) Interactions between drugs and nutrients. Advances in Pharmacology, 35, 1–26

    Article  PubMed  CAS  Google Scholar 

  14. DePonti F, Giaroni C, Cosentino M, Lecchini S, Frigo G (1996) Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacology and Therapeutics, 69, 59–78

    Article  CAS  Google Scholar 

  15. Roe DA (1993) Drug and food interactions as they affect the nutrition of older individuals. Aging: Clinical Experimental Research, 5, 51–53

    CAS  Google Scholar 

  16. Trovato A, Nuhlicek DN, Midtling JE (1991) Drug-nutrient interactions. American Family Physician, 44, 16541–1658

    Google Scholar 

  17. Winstanley PA, Orme ML’E (1989) The effects of food on drug bioavailability. British Journal of Clinical Pharmacology, 28, 621–628

    PubMed  CAS  Google Scholar 

  18. Hoyumpa AM, Schenker S (1982) Major drug interactions: effect of liver disease, alcohol, and malnutrition. Annual Reviews of Medicine, 33, 113–149

    Article  CAS  Google Scholar 

  19. Anderson KE and Kappas A (1987) How diet affects drug metabolism. Hospital Therapy, April, 93–102

    Google Scholar 

  20. Anderson KE (1988) Influences of diet and nutrition on clinical pharmacokinetics. Clinical Pharmacokinetics, 14, 325–346

    Article  PubMed  CAS  Google Scholar 

  21. Pantuck EJ, Pantuck CB, Weissman C, et al. (1984) Effects of parenteral nutritional regimens on oxidative drug metabolism. Anesthesiology, 60, 534–536

    Article  PubMed  CAS  Google Scholar 

  22. Bennett WM and Porter GA (1993) Overview of clinical nephrotoxicity. In Toxicology of the Kidney, 2 edn, Hook JB and Goldstein RS (eds), Target Organ Toxicity Series, Raven Press, New York, Chapter 3, 61–97

    Google Scholar 

  23. Charman WN, Porter CJH, Mithani S, Dressman JB (1997) Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH. Journal of Pharmaceutical Sciences, 86, 3, 269–282

    Article  PubMed  CAS  Google Scholar 

  24. Bliss DZ, Guenter PA, Settle RG (1992) Defining and reporting diarrhea in tube-fed patients - what a mess! AM J Clin Nutr, 55, 753–759

    PubMed  CAS  Google Scholar 

  25. Zaloga GP, Chernow B, Pock A, et al. (1984) Hypomagnesemia is a common complication of aminoglycoside therapy. Surg Gynecol Obstet, 158, 561–565

    PubMed  CAS  Google Scholar 

  26. Edes TE, Walk BE, Austin JL (1990) Diarrhea in tube-fed patients: feeding formula not necessarily the cause. Am J Med, 88, 91–93

    Article  PubMed  Google Scholar 

  27. Banerjee AK, Patel KJ, and Grainger SL (1989) Drug-induced acute pancreatitis: a critical review. Med. Toxicol. Adverse Drug Exp., 4, 186–198

    CAS  Google Scholar 

  28. Rünzi M, Layer P (1996) Drug-associated pancreatitis: facts and fiction. Pancreas, 13 (1), 100–109

    Article  PubMed  Google Scholar 

  29. Bennett WM (1997) Drug interactions and consequences of sodium restriction. American Journal of Clinical Nutrition, 65, 6785–6815

    Google Scholar 

  30. Halevy J, Bulvik S (1988) Severe hypophosphatemia in hospitalized patients. Arch Intern Med, 148, 153–155

    Article  PubMed  CAS  Google Scholar 

  31. Brady HR, Ryan F, Cunningham J, et al. (1989) Hypophosphatemia complicating bronchodilator therapy for acute severe asthma. Arch Intern Med, 149, 2367–2368

    Article  PubMed  CAS  Google Scholar 

  32. Sheehan J, White A (1982) Diuretic-associated hypomagnesemia. BMJ, 285,1157–1159

    Article  PubMed  CAS  Google Scholar 

  33. Nozue T, Kobayashi A, Kodama T, et al. (1992) Pathogenesis of cyclosporine-induced hypomagnesemia. J Pediatr, 120, 638–640

    Article  PubMed  CAS  Google Scholar 

  34. Schilsky RL, Anderson T (1979) Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med, 90, 929–931

    PubMed  CAS  Google Scholar 

  35. Parr MD, Record KE, Griffith GI, et al. (1982) Effect of enteral nutrition on Warfarin therapy. Clin Pharm, 1, 274–276

    PubMed  CAS  Google Scholar 

  36. Martin JE, Lutomski DM (1989) Warfarin resistance and enteral feedings. JPEN, 13, 206–208.

    Article  CAS  Google Scholar 

  37. Kuhn TA, Garnett WR, Wells BK, et al. (1989) Recovery of Warfarin from an enteral nutrient formula. Am J Hosp Pharm, 46, 1395–1399

    PubMed  CAS  Google Scholar 

  38. Wells S, Holbrook AM, Crother NR, Hirsh J (1994) Interactions of Warfarin with drugs and food. Annals of Internal Medicine, 121, 676–683

    PubMed  CAS  Google Scholar 

  39. Harris JE (1995) Interaction of dietary factors with oral anticoagulants: review and applications. Journal of the American Dietetic Association, 95, 580–584

    Article  PubMed  CAS  Google Scholar 

  40. Gal P, Layson R (1986) Interference with oral theophylline absorption by continuous nasogastric feedings. Ther Drug Monitor, 8, 421–423

    Article  CAS  Google Scholar 

  41. Jonkman JHG (1989) Food interactions with sustained-release theophylline preparations: a review. Clin Pharmacokinet, 16, 162–179

    Article  PubMed  CAS  Google Scholar 

  42. Plezia PM, Thornley SM, Kramer TH, et al. (1990) The influence of enteral feedings on sustained-release theophylline absorption. Pharmacotherapy, 10, 356–361

    PubMed  CAS  Google Scholar 

  43. Schaaf LJ, Bhargava VO, Berlinger WG, et al. (1989) Effect of an enteral formula on sustained-release theophylline absorption (abstract). Pharmacotherapy, 9, 185

    Google Scholar 

  44. Coutts RT (1994) Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping. J Psychiatry Neurosci, 19, 30–44

    PubMed  CAS  Google Scholar 

  45. Soto J, Alsar MJ, Sacristan JA (1995) Assessment of the time course of drugs with inhibitory effects of hepatic metabolic activity using successive salivary caffeine tests. Pharmacotherapy, 15, 781–784

    PubMed  CAS  Google Scholar 

  46. Shinn AF (1992) Clinical relevance of cimetidine drug interactions. Drug Safety, 7, 245–267

    Article  PubMed  CAS  Google Scholar 

  47. Bauer LA (1982) Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology, 32, 570–572

    PubMed  CAS  Google Scholar 

  48. Boucher BA, Rodman JH, Jaresko GS, et al. (1988) Phenytoin pharmacokinetics in critically ill trauma patients. Clin Pharmacol Ther, 44, 675–683

    Article  PubMed  CAS  Google Scholar 

  49. Schneider PJ, Mirtallo J (1983) Medication profiles in TPN patients. Nutr Supp Serv, 3, 40–46.

    Google Scholar 

  50. Gottschlich MM, Matarse LEA, Shronts EP. Nutrition Support Dietetics Core Curriculum, 2 ed., Silver Spring, MD: Aspen, 1992

    Google Scholar 

  51. Lieber CS (1994) Mechanisms of ethanol-drug-nutrition interactions. Clinical Toxicology, 32,631–681

    Article  PubMed  CAS  Google Scholar 

  52. Hussar DA (1988) Drug interactions in the older patient. Geriatrics, 43, 20–30

    PubMed  Google Scholar 

  53. Thomas JA, Stargel WW, Tschanz C (1998) Interactions between drugs and diet. Nutrition and Chemical Toxicity, ed. C Ioannides, J Wiley & Sons Ltd., p 161–182

    Google Scholar 

  54. Katz NL, Dejean A (1985) Interrelationships between drugs and nutrients. Pharm Index, December, 9–15

    Google Scholar 

  55. Kirk JK (1995) Significant drug-nutrient interactions. Am Fam Physician, 51 (45), 1175–82

    PubMed  CAS  Google Scholar 

  56. Mehta S, Nain CK, Sharma B, Mathur VS (1982) Disposition of four drugs in malnourished children. Drug-Nutrient Interactions, 1, 205–211

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thomas, J.A., Stargel, W.W., Cotter, R. (2002). Drug-Nutrient Interactions in the Critically III. In: Pichard, C., Kudsk, K.A. (eds) From Nutrition Support to Pharmacologic Nutrition in the ICU. Update in Intensive Care Medicine, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57119-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57119-0_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42604-2

  • Online ISBN: 978-3-642-57119-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics